Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Company News

GSK names Walmsley to succeed Witty

September 20, 2016 7:00 AM UTC

GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) said Emma Walmsley will succeed Sir Andrew Witty as CEO on March 31, 2017. Walmsley is CEO of GSK's Consumer Healthcare division.

GSK said in March that Witty planned to retire. He has been CEO since 2008 (see BioCentury Extra, March 17). ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article